FDA records indicate that there are no current recalls for this drug.
Are you a medical professional?
Trending Topics
Revalor-xs Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
Not to be used in animals intended for subsequent breeding, or in dairy animals. For Animal Treatment Only. Not for Use in Humans. Implant pellets in the ear only. Any other location is in violation of Federal Law. Do not attempt salvage of implanted site for human or animal food.
A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in calves to be processed for veal.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
There is currently no usage information available for this product. We apologize for any inconvenience.
History
There is currently no drug history available for this drug.
Other Information
Revalor®-XS (trenbolone acetate, CAS Registry Number 10161-34-9, and estradiol, CAS Registry Number 50-28-2) is an implant containing 200 mg of trenbolone acetate and 40 mg estradiol. Each implant consists of 10 small yellow pellets. Ten implants are provided in a cartridge.
Manufactured by a non-sterilizing process.
Sources
Revalor-xs Manufacturers
-
Merck Sharp & Dohme Corp.
Revalor-xs | Merck Sharp & Dohme Corp.
One implant containing 200 mg trenbolone acetate and 40 mg estradiol is administered to each animal. The 10 pellets which make up the dosage of Revalor®-XS are contained in one division of the multiple dose cartridge. Ten doses are in each cartridge. The cartridge is designed to be used with a special implant gun.
Login To Your Free Account